Plumbline Life Sciences, Inc. (XKON:A222670) announced a private placement of series 2 unregistered coupon unguranteed unsecured private convertible bonds for KRW 450,000,000 on August 8, 2019. The transaction will include participation from EuBiologics Co., Ltd for KRW 450,000,000. The bonds will carry no coupon rate and yield to maturity rate of 4%. The debentures are will be convertible into 45,000 common shares of the company at a fixed conversion price of KRW 10,000 per share. The debentures will mature on August 16, 2022. The conversion period starts from August 16, 2020 to July 16, 2022. The payment date is on August 16, 2019. The transaction was approved by board of directors of the company.